Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Fibroblasts”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Ended earlyNCT02810951
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Castle Creek Biosciences, LLC. 6
Not applicableLooking for participantsNCT06516939
What this trial is testing

The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin

Who this might be right for
Sensitive Skin
Shanghai Dermatology Hospital 28
Not applicableEnrolling By InvitationNCT06786754
What this trial is testing

Fibroblasts and Thoracic Aortic Aneurysms: in Vitro Characterization in With Marfan Syndrome and Genetic Aortic Diseases

Who this might be right for
Rare DiseasesThoracic Aortic Aneurysm (TAA)Marfan Syndrome
IRCCS Policlinico S. Donato 15
Not applicableStudy completedNCT04035811
What this trial is testing

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 271
Not applicableLooking for participantsNCT05273138
What this trial is testing

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University Hospital, Lille 40
Testing effectiveness (Phase 2)Study completedNCT04485962
What this trial is testing

Treatment of Patients With Skin Burns Using Keratinocytes and Skin Fibroblasts

Who this might be right for
Burns
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 12
Not applicableEnrolling By InvitationNCT00895271
What this trial is testing

Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

Who this might be right for
Primary ImmunodeficiencyDOCK8Virus Susceptibility
National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Study completedNCT04483934
What this trial is testing

Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts

Who this might be right for
Trophic UlcerNon-healing WoundNon-Healing Ulcer of Skin
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 12
Early research (Phase 1)Study completedNCT02627274
What this trial is testing

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Who this might be right for
Solid TumorBreast CancerCancer of Head and Neck
Hoffmann-La Roche 134
Not applicableUnknownNCT05755321
What this trial is testing

From Skin Fibroblasts to Neural Stem Cells to Investigate in Vitro the Impact of Diabetes on Adult Neurogenesis

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 in ObeseDiabetes Mellitus Type 2 in Nonobese+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Large-scale testing (Phase 3)Looking for participantsNCT06745557
What this trial is testing

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

Who this might be right for
Burns
CUTISS AG 70
Not applicableStudy completedNCT01348581
What this trial is testing

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Who this might be right for
Pressure UlcersVenous UlcersDiabetic Ulcers+2 more
Kerecis Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Not applicableNot Yet RecruitingNCT07113418
What this trial is testing

Role of FGF21 in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 84
Not applicableLooking for participantsNCT06410976
What this trial is testing

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 150
Not applicableStudy completedNCT00001166
What this trial is testing

Gyrate Atrophy of the Choroid and Retina

Who this might be right for
Gyrate Atrophy
National Eye Institute (NEI) 65
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05145010
What this trial is testing

Extension Study of Infigratinib in Children With Achondroplasia (ACH)

Who this might be right for
Achondroplasia
QED Therapeutics, a BridgeBio company 300
Early research (Phase 1)Looking for participantsNCT07213791
What this trial is testing

LY4337713 in Participants With FAP-Positive Solid Tumors

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+4 more
Eli Lilly and Company 241
Testing effectiveness (Phase 2)Study completedNCT00049530
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 32
Load More Results